IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 159 filers reported holding IMMUNOMEDICS INC in Q3 2017. The put-call ratio across all filers is 0.59 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $216,153,000 | +79.8% | 2,542,082 | -25.0% | 2.06% | +65.9% |
| Q2 2020 | $120,196,000 | +69.9% | 3,391,543 | -35.4% | 1.24% | +33.7% |
| Q1 2020 | $70,725,000 | -38.0% | 5,246,689 | -2.7% | 0.93% | -8.5% |
| Q4 2019 | $114,111,000 | +63.2% | 5,392,769 | +2.3% | 1.02% | +45.4% |
| Q3 2019 | $69,904,000 | +7.0% | 5,271,782 | +11.9% | 0.70% | +11.1% |
| Q2 2019 | $65,333,000 | -15.9% | 4,710,350 | +16.5% | 0.63% | -14.2% |
| Q1 2019 | $77,674,000 | +36.9% | 4,043,436 | +1.7% | 0.73% | +22.8% |
| Q4 2018 | $56,741,000 | -29.7% | 3,976,220 | +2.6% | 0.60% | -11.8% |
| Q3 2018 | $80,761,000 | -20.9% | 3,877,150 | -10.1% | 0.68% | -27.9% |
| Q2 2018 | $102,069,000 | +41.2% | 4,312,171 | -12.9% | 0.94% | +29.8% |
| Q1 2018 | $72,296,000 | -14.4% | 4,948,385 | -5.3% | 0.72% | -15.6% |
| Q4 2017 | $84,438,000 | +71.6% | 5,225,124 | +48.5% | 0.86% | +53.0% |
| Q3 2017 | $49,203,000 | +291.6% | 3,519,500 | +147.3% | 0.56% | +258.3% |
| Q2 2017 | $12,566,000 | +18.3% | 1,423,117 | -13.3% | 0.16% | +7.6% |
| Q1 2017 | $10,622,000 | +89.8% | 1,641,689 | +7.7% | 0.14% | +64.8% |
| Q4 2016 | $5,595,000 | +9383.1% | 1,524,475 | +8360.8% | 0.09% | +8700.0% |
| Q3 2016 | $59,000 | +51.3% | 18,018 | +8.2% | 0.00% | 0.0% |
| Q2 2016 | $39,000 | – | 16,659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |